Mr. Stephen Van Deventer reports

PREVECEUTICAL PROVIDES UPDATE ON MANAGEMENT CEASE TRADE ORDER

Preveceutical Medical Inc. has filed its audited annual financial statements and accompanying management's discussion and analysis, with related CEO (chief executive officer) and CFO (chief financial officer) certificates, for the financial year ended Dec. 31, 2023 (collectively, the annual filings). The annual filings are available on SEDAR+ as well as the Canadian Securities Exchange website.

As previously announced, in connection with the delay by the company in filing its annual filings, the company is under a voluntary management cease trade order (MCTO) issued by the British Columbia Securities Commission (the BCSC) under National Policy 12-203 -- Management Cease Trade Orders, effective as of May 2, 2024. The company could not proceed to file its interim financial statements, accompanying management's discussion and analysis, and related CEO and CFO certificates for the period ended March 31, 2024, prior to filing the outstanding annual filings in accordance with applicable Canadian securities laws and as such, the company was unable to complete the Q1 filings prior to the May 30, 2024, deadline.

The company expects to file the Q1 filings as soon as they are available, and in any event no later than July 5, 2024. Once the Q1 filings are completed, the company expects to be up to date with its required filings and that the MCTO will be revoked by the BCSC.

The company is providing this status update in accordance with NP 12-203. Until the company files the Q1 filings, it will comply with the alternative information guidelines set out in NP 12-203, including the issuance of biweekly default status reports in the form of news releases.

The company confirms as of the date of this news release that there has been no material change in the information contained in the default announcement issued on May 2, 2024, and the default status reports issued May 16, 2024, May 30, 2024, and June 14, 2024, and there is no other material information concerning the affairs of the company that has not been generally disclosed.

About Preveceutical Medical Inc.

Preveceutical is a health sciences company focused on developing innovative options for preventive and curative therapies utilizing organic and nature identical products. The company aims to be a leader in the preventive health sciences sector.

With the completion of three of its research programs, the company is actively working on the development, clinical trials and commercialization of its products; and has filed a number of provisional patent applications to protect the intellectual property from its research programs.

We seek Safe Harbor.